Traws Pharma, Inc. SEC filings TRAW
Traws Pharma, Inc. has 988 filings in SEC EDGAR's recent list, going back to Jan 8, 2003. Its latest annual report, Form ARS, was filed on May 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-1 | Registration statement | Oct 26, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 23, 2026 | Oct 23, 2026 |
| DEFA14A | Additional proxy material | Oct 20, 2026 | — |
| DEF 14A | Proxy statement | Oct 20, 2026 | Dec 3, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 8, 2026 | Oct 8, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jul 31, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 16, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Other events
|
Jul 10, 2026 | Jul 10, 2026 |
| 424B5 | Prospectus supplement | Jul 10, 2026 | — |
| EFFECT | Filing | Jul 9, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 9, 2026 | Jul 8, 2026 |
| CORRESP | Letter to the SEC | Jul 7, 2026 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2026 | — |
| S-3 | Shelf registration | Jul 1, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2026 | Jun 12, 2026 |
| ARS | Annual report to shareholders | May 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | May 29, 2026 | — |
| DEF 14A | Proxy statement | May 29, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 22, 2026 |
| 424B5 | Prospectus supplement | May 22, 2026 | — |
| PRE 14A | Preliminary proxy statement | May 19, 2026 | May 19, 2026 |
| EFFECT | Filing | May 15, 2026 | — |
| 424B3 | Prospectus | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2026 | May 15, 2026 |
| CORRESP | Letter to the SEC | May 13, 2026 | — |
| UPLOAD | Letter from the SEC | May 12, 2026 | — |
| S-3 | Shelf registration | May 8, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 5, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Apr 28, 2026 | Apr 16, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 15, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 15, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 8, 2026 | Oct 12, 2025 |
| 3 | Initial insider ownership | Apr 8, 2026 | Jul 3, 2025 |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 8, 2026 |
| 8-K |
Current report
Other events
|
Feb 19, 2026 | Feb 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 26, 2026 | Jan 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 16, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Other events
|
Dec 17, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 28, 2025 | Nov 21, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 12, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 1, 2025 |
| 3 | Initial insider ownership | Oct 14, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Oct 14, 2025 |
| ARS | Annual report to shareholders | Oct 8, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Oct 8, 2025 | — |
| DEF 14A | Proxy statement | Oct 8, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 6, 2025 | Oct 1, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 19, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Sep 12, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 18, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 30, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 19, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 19, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 19, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 27, 2025 | May 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2025 | May 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2025 | — |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 18, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Other events
|
Apr 7, 2025 | Apr 7, 2025 |
| 424B5 | Prospectus supplement | Apr 7, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Other events
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Other events
|
Mar 21, 2025 | Mar 21, 2025 |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 8-K |
Current report
Material agreement
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Other events
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 28, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 19, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Feb 18, 2025 | Feb 17, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2025 | — |
| 4 | Insider transaction | Feb 10, 2025 | Feb 5, 2025 |
| 3 | Initial insider ownership | Feb 7, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2025 | Feb 5, 2025 |
| DEF 14A | Proxy statement | Feb 6, 2025 | Feb 17, 2025 |
| 424B3 | Prospectus | Jan 31, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 29, 2025 | — |
| 4 | Insider transaction | Jan 27, 2025 | Dec 29, 2024 |
| 4 | Insider transaction | Jan 27, 2025 | Dec 29, 2024 |
| 4 | Insider transaction | Jan 27, 2025 | Dec 29, 2024 |
| 4 | Insider transaction | Jan 27, 2025 | Dec 29, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 27, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Other events
|
Jan 23, 2025 | Jan 23, 2025 |
| EFFECT | Filing | Jan 22, 2025 | — |
| CORRESP | Letter to the SEC | Jan 17, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2025 | — |
| S-3 | Shelf registration | Jan 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 31, 2024 | Dec 29, 2024 |
| 424B4 | Prospectus | Dec 31, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 22, 2024 | Nov 20, 2024 |
| S-8 | Employee stock plan registration | Nov 15, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 6, 2024 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Nov 1, 2024 | Oct 29, 2024 |
| ARS | Annual report to shareholders | Oct 23, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Oct 11, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 27, 2024 | Sep 24, 2024 |
| SC 13D | Ownership over 5% (active) | Sep 23, 2024 | — |
| 3 | Initial insider ownership | Sep 23, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Sep 17, 2024 | Sep 16, 2024 |
| 424B3 | Prospectus | Aug 30, 2024 | — |
| EFFECT | Filing | Aug 28, 2024 | — |
| CORRESP | Letter to the SEC | Aug 26, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2024 | — |
| 8-K |
Current report
Listing notice
|
Aug 23, 2024 | Aug 23, 2024 |
| CORRESP | Letter to the SEC | Aug 16, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 15, 2024 | Aug 15, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Aug 15, 2024 | Jun 30, 2024 |
| DEF 14A | Proxy statement | Aug 9, 2024 | Sep 16, 2024 |
| 4/A | Filing | Aug 7, 2024 | Apr 1, 2024 |
| 4/A | Filing | Aug 7, 2024 | Apr 1, 2024 |
| CORRESP | Letter to the SEC | Jul 30, 2024 | — |
| PRER14A | Filing | Jul 30, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2024 | — |
| 8-K |
Current report
Auditor change
|
Jul 19, 2024 | Jul 16, 2024 |
| UPLOAD | Letter from the SEC | Jul 15, 2024 | — |
| S-3 | Shelf registration | Jul 1, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newtown, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1130598
- Former names
- Onconova Therapeutics, Inc. (until Apr 1, 2024); ONCONOVA THERAPEUTICS INC (until May 26, 2009)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.